CA153、CA125、CA19-9、CA72-4水平与非小细胞肺癌术后患者预后的关系研究OA
The Relationship between CA153,CA125,CA19-9,and CA72-4 Levels and the Prognosis of Postoperative Non-Small Cell Lung Cancer Patients
目的:研究糖类抗原 153(CA153)、研究糖类抗原 125(CA125)、研究糖类抗原 19-9(CA19-9)、研究糖类抗原 72-4(CA72-4)水平与非小细胞肺癌(NSCLC)术后患者预后的关系.方法:回顾性分析 2019 年 1 月—2023 年 4 月南京市高淳中医院收治的 278 例行NSCLC 根治性切除术的患者的临床资料,根据术后 2 年随访结果分为预后良好组(n=115)和预后不良组(n=163).比较不同预后情况患者的临床资料、CA153、CA125、CA19-9、CA72-4 水平,分析 CA153、CA125、CA19-9、CA72-4 水平在患者预后评估的作用.结果:预后不良组年龄、吸烟史患者比率、淋巴结转移患者比率、肿瘤-淋巴结-转移分期系统(TNM 分期)Ⅲ、Ⅳ期患者比率、CA153、CA125、CA19-9、CA72-4水平明显高于预后良好组,差异均有统计学意义(P<0.05).相关性分析显示,各标志物间呈低度至中度正相关,VIF均<2,不存在严重共线性.logistic回归分析显示,淋巴结转移、TNM分期、CA153、CA125、CA19-9、CA72-4水平均为预后不良的独立危险因素(P<0.05).ROC曲线表明,CA153、CA125、CA19-9、CA72-4水平联合预测预后的AUC为0.897,优于单一标志物,联合淋巴结转移、TNM分期后AUC进一步提升至0.909,根据约登指数确定本中心最佳截断值分别为31.52 U/mL、61.38 U/mL、49.75 U/mL、41.63 U/mL.结论:CA153、CA125、CA19-9、CA72-4 升高是 NSCLC 术后预后不良的独立预测因子,联合检测可显著提升预后评估效能,本研究在本地化单中心人群中验证了上述标志物的预测价值,并确定了本中心的最佳截断值,为本地区NSCLC 术后管理提供了区域性循证依据.
Objective:To study the relationship between the levels of carbohydrate antigen 153(CA153),carbohydrate antigen 125(CA125),carbohydrate antigen 19-9(CA19-9),and carbohydrate antigen 72-4(CA72-4)and the prognosis of postoperative patients with non-small cell lung cancer(NSCLC).Method:A retrospective analysis was conducted on the clinical data of 278 patients who underwent radical resection of NSCLC in Gaochun Hospital of Traditional Chinese Medicine,Nanjing from January 2019 to April 2023.According to the follow-up results at 2 years after the operation,they were divided into the good prognosis group(n=115)and the poor prognosis group(n=163).The clinical data,CA153,CA125,CA19-9 and CA72-4 levels of patients with different prognostic conditions were compared,and the role of CA153,CA125,CA19-9 and CA72-4 levels in the prognosis assessment of patients were analyzed.Result:The age,the ratio of patients with a smoking history,the ratio of patients with lymph node metastasis,the ratio of patients at stage Ⅲ and Ⅳ of the tumor-lymph node metastasis staging system(TNM staging),and the levels of CA153,CA125,CA19-9,and CA72-4 in the poor prognosis group were significantly higher than those in the good prognosis group,and all the differences were statistically significant(P<0.05).Correlation analysis showed that there was a low to moderate positive correlation among the markers,and the VIF was all<2,with no severe collinearity.Logistic analysis showed that lymph node metastasis,TNM stage,CA153,CA125,CA19-9,and CA72-4 levels were all independent risk factors for poor prognosis(P<0.05).The ROC curve indicated that the combined AUC of CA153,CA125,CA19-9,and CA72-4 levels for predicting prognosis reached 0.897,which was superior to that of a single marker.After combining lymph node metastasis and TNM staging,the AUC further increased to 0.909.Based on the Youden Index,the optimal cut-off values of this center were determined to be 31.52 U/mL,61.38 U/mL,49.75 U/mL,and 41.63 U/mL respectively.Conclusion:Elevated CA153,CA125,CA19-9,and CA72-4 are independent predictors of poor prognosis after NSCLC surgery.Combined detection can significantly enhance the efficacy of prognosis assessment.This study verified the predictive value of the above markers in a localized single-center population and determined the optimal cut-off value of this center.It provides regional evidence-based basis for the postoperative management of NSCLC in this region.
吴勇
南京市高淳中医院 江苏 南京 211300
糖类抗原153糖类抗原125糖类抗原19-9糖类抗原72-4非小细胞肺癌
Carbohydrate antigen 153Carbohydrate antigen 125Carbohydrate antigen 19-9Carbohydrate antigen 72-4Non-small cell lung cancer
《中外医学研究》 2026 (11)
9-13,5
评论